Maurer was right: Give people relief
It is time for competent Hoosiers suffering at the end of their lives to have access to all modern medicines
for humane relief.
It is time for competent Hoosiers suffering at the end of their lives to have access to all modern medicines
for humane relief.
Companies are helping workers age 65 and above decide whether to forgo their company health insurance and shift to Medicare.
Medicare is becoming more attractive as costs of company policies rise.
It’s no secret that Eli Lilly and Co. is the biggest private employer in the Indianapolis area. But
Lilly also supplemented the incomes of a few dozen local doctors — to the tune of more than $224,000 in just the first
quarter.
In almost every place that two or more Americans gather, health care is debated. Because the bills before Congress are
inaccessible, the debate has shifted instead to principles such as the role of government and individual freedoms. I think this a healthy thing.
We lost a member of the family last month. Casey Elizabeth Maurer died a peaceful death at her age of 105. At the end,
her hearing and eyesight were vastly impaired and she was in constant pain. Her time had come.
One of the biggest challenges facing our nation is health care reform. Despite development of the most innovative and significant
advances in medical treatment, our ability as health care professionals to provide high-quality, cost-effective and continual
patient care too often falls by the wayside as a result of misalignments in our health care system.
In the eyes of Scott Law, Congress is heading in exactly the wrong direction on health care reform.
But the
CEO of Zotec Partners predicts a big bump in sales for his physician-billing management company if current reform proposals
become law.
A panel of five leaders of the state’s life sciences
industry took on a wide range of topics
July 24 at IBJ’s Power Breakfast
at the Westin Indianapolis.
More emerging life science companies have found life in the form of federal
Small Business Innovation Research grants.
Eli Lilly and Co. has blasted past analysts’ earnings projections for two straight quarters. But if Lilly officials
take that as a sign they can breathe easier, they need only flip through a stack of Wall Street research reports on the company.
As concern grows among medical providers that health care reform augurs lower payments, St. Francis
Hospital & Health Centers has agreed to absorb a large group of cardiologists that bring lucrative heart patients to its
facilities.
The Indiana State Medical Association has filed a formal complaint against Anthem Blue Cross and Blue Shield of Indiana for ongoing claims-payment issues. The doctors group, in an announcement today, contends that computer problems at Anthem have yet to be resolved, breaching a 2005 court settlement reached by doctors and Anthem’s parent company, Indianapolis-based WellPoint […]
If you want to see a physical therapist in Indiana, you must first see a physician for a consultation
and referral. It’s the law. Indiana is one of only six states where patients are denied direct
access to physical therapy treatment, and one of only two states where evaluation without referral is
prohibited.
Favorable article in prestigious journal could draw attention to Carmel biotech startup.
A state law that went into effect July 1 attempts to attract young physicians and mental health practitioners to underserved
areas by forgiving part of their student loans. But Indiana’s budget woes prevented lawmakers from allocating funds
to support the program.
Health care marketers can adapt to, and even use to their advantage, the online search habits of consumers.
Understanding when and why people search for specific health-related terms is vital to attracting more
visitors (i.e. patients) to a Web site.
I read with interest IBJ’s [June 29 story] focusing on health care reform. I was not surprised by the exclusion
of opinions from “real” private-practice physicians.
Eli Lilly and Co.’s top rising-star drug has been approved by U.S. regulators for a new use, an event that could boost sales of
the medication. Alimta, a lung cancer drug, was approved as a maintenance therapy for non-small cell lung cancer
for certain patients, Lilly announced today.
Eli Lilly and Co.’s top rising-star drug has been OK’d by U.S. regulators for a new use, an event that could boost sales of the medication. Alimta, a lung cancer drug, was approved as a maintenance therapy for non-small cell lung cancer for certain patients, Lilly announced today. The approval by the U.S. Food and […]
As expected, AIT Laboratories CEO Michael A. Evans has transferred ownership of the company to its workers through an employee stock ownership plan, or ESOP, the company announced today. The Indianapolis-based company declined to reveal the price of the sale. Fast-growing AIT Laboratories previously said it would make “a major announcement” today with Indiana Treasurer […]